Mandate

Vinge has advised Active Biotech on private placement

February 03, 2011

Active Biotech AB (publ) (NASDAQ OMX Stockholm) has carried out a private placement of new shares of SEK 375 million directed towards international institutional investors and qualified investors in Sweden.

Vinge acted for Active Biotech. Vinge’s team consisted of Erik Sjöman and Christian Lindhé.

Related

Vinge advises Stockwik Förvaltning in conjunction with the acquisition of Labino

Vinge has advised Stockwik Förvaltning in connection with its acquisition of Labino, a world-leading Swedish manufacturer of industrial UV light fixtures.
December 19, 2025

Vinge advises Revivo Group in conjunction with the acquisition of Nordisk Ytbehandling

Vinge has advised Revivo Group in connection with the acquisition of Nordisk Ytbehandling, a well-established contracting company based in Nyköping specialising in blasting as well as anti-corrosion and fire protection painting, with a solid customer base within the industrial and infrastructure sectors.
December 19, 2025

Vinge advises on the sale of NCS Colour

Vinge has advised Sobro and other owners in conjunction with Helix Kapital becoming a new owner partner in NCS Colour, together with the management team.
December 19, 2025